KRAS and pancreatic adenocarcinoma: In the pancreatic adenocarcinoma dataset of TCGA consortium, 131 of 140 patients harboring KRAS mutations were clonal (KRASG12mut), whereas others (9/140; 6.4%) had subclonal mutations at codons 12 and 6138.